Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OABI - OmniAb Inc

IEX Last Trade
4.19
-0.080   -1.909%

Share volume: 427,837
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$4.27
-0.08
-1.87%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
20%
Profitability 0%
Dept financing 5%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.10%
1 Month
-12.34%
3 Months
-6.47%
6 Months
-32.53%
1 Year
-28.50%
2 Year
73.86%
Key data
Stock price
$4.19
P/E Ratio 
-7.94
DAY RANGE
$4.16 - $4.32
EPS 
-$0.62
52 WEEK RANGE
$3.56 - $6.72
52 WEEK CHANGE
-$0.28
MARKET CAP 
495.102 M
YIELD 
N/A
SHARES OUTSTANDING 
118.163 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.13
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$469,810
AVERAGE 30 VOLUME 
$469,395
Company detail
CEO:
Region: US
Website:
Employees: 59
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

the omniab discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

Recent news